Afstyla

List of products in the National Drug Code with proprietary name afstyla. This medication is used to control and prevent bleeding episodes in people with low levels of factor VIII (hemophilia A). It is also used in these patients before surgery to prevent bleeding. People with low factor VIII levels are at risk for bleeding longer after an injury/surgery and for bleeding inside the body (especially into the joints and muscles). This product contains a man-made form of factor VIII, also called antihemophilic factor. This product is used to temporarily replace the missing factor VIII, a protein (clotting factor) that is normally in the blood, so that the blood can clot and the bleeding can stop. This medication should not be used to treat von Willebrand disease.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
69911-474Afstyla Antihemophilic Factor (Recombinant), Single ChainAntihemophilic Factor, Human RecombinantKitCsl Behring Lengnau AgPlasma Derivative
69911-475Afstyla Antihemophilic Factor (Recombinant), Single ChainAntihemophilic Factor, Human RecombinantKitCsl Behring Lengnau AgPlasma Derivative
69911-476Afstyla Antihemophilic Factor (Recombinant), Single ChainAntihemophilic Factor, Human RecombinantKitCsl Behring Lengnau AgPlasma Derivative
69911-477Afstyla Antihemophilic Factor (Recombinant), Single ChainAntihemophilic Factor, Human RecombinantKitCsl Behring Lengnau AgPlasma Derivative
69911-478Afstyla Antihemophilic Factor (Recombinant), Single ChainAntihemophilic Factor, Human RecombinantKitCsl Behring Lengnau AgPlasma Derivative
69911-480Afstyla Antihemophilic Factor (Recombinant), Single ChainAntihemophilic Factor, Human RecombinantKitCsl Behring Lengnau AgPlasma Derivative
69911-481Afstyla Antihemophilic Factor (Recombinant), Single ChainAntihemophilic Factor, Human RecombinantKitCsl Behring Lengnau AgPlasma Derivative